Malingering and Addiction in the Treatment of Sleep Disorders
According to the National Sleep Foundation (2013), about 30–40% of the general population reports some level of insomnia during their lives, and 10–15% experience significant, chronic insomnia. For these individuals, medications to help induce and sustain sleep may be helpful. On the other hand, sleep aids pose potential concerns, namely abuse. Some people exceed recommended doses, and some continue taking medications even after symptoms are no longer present. Others obtain medications under false pretenses, which is one form of malingering. Malingering occurs when clients make up or exaggerate symptoms for some personal gain. Although mental health professionals may not be directly implicated in the client’s deceit, their unique position to receive more accurate and honest information than other medical professionals presents ethical concerns. What is the mental health professional’s role in these instances? In which instances would it be appropriate to break confidentiality due to a concern of malingering? How could the malingering potentiality be planned for and avoided?
For this Assignment, conduct an Internet search or a Walden Library search for at least one peer-reviewed journal article that addresses a counseling issue related to malingering and addiction in treating sleep disorder
In a 3- to 5-page, APA-formatted paper, include the followingl:
A description and explanation of the major types of drugs prescribed for sleep disorders
An explanation of the potential for addiction associated with these medicines
An explanation of the issues related to malingering in the treatment of sleep disorders
An explanation of the mental health professional’s role in mitigating the potentialities of malingering
Be sure to support your postings and responses with specific references to the Learning Resources APA 7th addition format intext citations and full references
Lichtblau, L. (2011). Psychopharmacology demystified. Clifton Park, NY: Delmar, Cengage Learning.
Chapter 6, “Anxiolytic-Sedative-Hypnotic Drug Pharmacotherapy” (previously read in Week 5)
Preston, J. D., O’Neal, J. H., & Talaga, M. C. (2017). Handbook of clinical psychopharmacology for therapists (8th ed.). Oakland, CA: New Harbinger.
Chapter 15, “Other Miscellaneous Disorders” (pp. 161-174)